Deletion of Blimp-1, which prevents plasma cell differentiation, initially enhanced B1/CLL formation in young mice but nearly halted CLL progression, highlighting the significant influence of autoimmune complications on disease outcomes. The gene discussed is PRDM1; the disease is B-cell chronic lymphocytic leukemia.